Millendo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MLND and buy or sell other stocks, ETFs, and their options commission-free!About MLND
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
CEOStephen R. Brady
CEOStephen R. Brady
Employees25
Employees25
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees25
Employees25
MLND Key Statistics
Market cap18.34M
Market cap18.34M
Price-Earnings ratio-0.68
Price-Earnings ratio-0.68
Dividend yield—
Dividend yield—
Average volume31.10K
Average volume31.10K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$15.08
52 Week high$15.08
52 Week low$5.35
52 Week low$5.35
Stock Snapshot
Millendo Therapeutics(MLND) stock is priced at $4.13, giving the company a market capitalization of 18.34M. It carries a P/E multiple of -0.68.
Millendo Therapeutics(MLND) stock opened on 2025-11-06 at —. The price climbed to — and dipped to —.
The Millendo Therapeutics(MLND)'s current trading volume is 0, compared to an average daily volume of 31.1K.
In the last year, Millendo Therapeutics(MLND) shares hit a 52-week high of $15.08 and a 52-week low of $5.35.
In the last year, Millendo Therapeutics(MLND) shares hit a 52-week high of $15.08 and a 52-week low of $5.35.
People also own
Based on the portfolios of people who own MLND. This list is generated using Robinhood data, and it’s not a recommendation.